91 related articles for article (PubMed ID: 447862)
1. Modulating influence of chemotactic factor-induced cell adhesiveness on granulocyte function.
Fehr J; Dahinden C
J Clin Invest; 1979 Jul; 64(1):8-16. PubMed ID: 447862
[TBL] [Abstract][Full Text] [Related]
2. Movement within and movement beyond: synaptotagmin-mediated vesicle fusion during chemotaxis.
Colvin RA; Luster AD
Cell Adh Migr; 2011; 5(1):56-8. PubMed ID: 20798599
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of recombinant human growth hormone-induced and prolactin-induced activation of neutrophils by octreotide.
Wiedermann CJ; Reinisch N; Niedermühlbichler M; Braunsteiner H
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):336-41. PubMed ID: 8097570
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion.
Kubes P; Jutila M; Payne D
J Clin Invest; 1995 Jun; 95(6):2510-9. PubMed ID: 7539452
[TBL] [Abstract][Full Text] [Related]
5. Prevention of neutrophil chemotactic deactivation by ascorbic acid.
Patrone F; Dallegri F; Lanzi G; Sacchetti C
Br J Exp Pathol; 1980 Oct; 61(5):486-9. PubMed ID: 7448116
[TBL] [Abstract][Full Text] [Related]
6. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Dahinden C; Fehr J
J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
[TBL] [Abstract][Full Text] [Related]
7. Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation.
Patrick RA; Hollers JC; Liu DY; Giese BH; Smith CW
Infect Immun; 1980 Jun; 28(3):700-7. PubMed ID: 7399690
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neutrophil migration by aggregated immunoglobulin attached to micropore membranes.
Kemp AS; Brown S
Immunology; 1980 Apr; 39(4):529-34. PubMed ID: 7380477
[TBL] [Abstract][Full Text] [Related]
9. Motility and adhesiveness in human neutrophils. Redistribution of chemotactic factor-induced adhesion sites.
Smith CW; Hollers JC
J Clin Invest; 1980 Apr; 65(4):804-12. PubMed ID: 7358846
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic factor-induced effects upon deformability of human polymorphonuclear leukocytes.
Kawaoka EJ; Miller ME; Cheung AT
J Clin Immunol; 1981 Jan; 1(1):41-4. PubMed ID: 7334069
[TBL] [Abstract][Full Text] [Related]
11. Human neutrophil aggregation and increased adherence to human endothelial cells induced by heat-aggregated IgG and immune complexes.
Hashimoto Y; Hurd ER
Clin Exp Immunol; 1981 Jun; 44(3):538-47. PubMed ID: 7326864
[TBL] [Abstract][Full Text] [Related]
12. Polymorphonuclear leukocyte migration through human amnion membrane.
Russo RG; Liotta LA; Thorgeirsson U; Brundage R; Schiffmann E
J Cell Biol; 1981 Nov; 91(2 Pt 1):459-67. PubMed ID: 7309792
[TBL] [Abstract][Full Text] [Related]
13. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
Anderson DC; Hughes BJ; Smith CW
J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
[TBL] [Abstract][Full Text] [Related]
14. In vitro effect of tobacco smoke components on the functions of normal human polymorphonuclear leukocytes.
Corberand J; Laharrague P; Nguyen F; Dutau G; Fontanilles M; Gleizes B; Gyrard E
Infect Immun; 1980 Dec; 30(3):649-55. PubMed ID: 7228386
[TBL] [Abstract][Full Text] [Related]
15. Degranulation, membrane addition, and shape change during chemotactic factor-induced aggregation of human neutrophils.
Hoffstein ST; Friedman RS; Weissmann G
J Cell Biol; 1982 Oct; 95(1):234-41. PubMed ID: 7142287
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-endothelial cell interactions on endothelial monolayers grown on micropore filters.
Taylor RF; Price TH; Schwartz SM; Dale DC
J Clin Invest; 1981 Feb; 67(2):584-7. PubMed ID: 7007441
[TBL] [Abstract][Full Text] [Related]
17. Comparison of adhesion to glass and aggregation of human leucocytes.
Damerau B; Keller HU
Agents Actions; 1983 Feb; 13(1):53-8. PubMed ID: 6858786
[TBL] [Abstract][Full Text] [Related]
18. Polymorphonuclear leukocyte function in ulcerative colitis and Crohn's disease.
Kirk AP; Cason J; Fordham JN; Brown KA; Goddard DH; Holborow EJ; Lennard-Jones JE
Dig Dis Sci; 1983 Mar; 28(3):236-48. PubMed ID: 6825543
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).
Valone FH; Goetzl EJ
Am J Pathol; 1983 Oct; 113(1):85-9. PubMed ID: 6624880
[TBL] [Abstract][Full Text] [Related]
20. Regulation of neutrophil migratory function in burn injury by complement activation products.
Solomkin JS; Nelson RD; Chenoweth DE; Solem LD; Simmons RL
Ann Surg; 1984 Dec; 200(6):742-6. PubMed ID: 6508405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
